BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11544346)

  • 1. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients.
    Benveniste O; Chérin P; Maisonobe T; Merat R; Chosidow O; Mouthon L; Guillevin L; Flahault A; Burland MC; Klatzmann D; Herson S; Boyer O
    J Immunol; 2001 Sep; 167(6):3521-9. PubMed ID: 11544346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
    Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
    J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
    Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
    Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis.
    Nishio J; Suzuki M; Miyasaka N; Kohsaka H
    J Immunol; 2001 Oct; 167(7):4051-8. PubMed ID: 11564826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
    Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
    Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis.
    Baka Z; Senolt L; Vencovsky J; Mann H; Simon PS; Kittel A; Buzás E; Nagy G
    Immunol Lett; 2010 Feb; 128(2):124-30. PubMed ID: 20043950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
    Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
    Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies.
    De Bleecker JL; Engel AG
    Am J Pathol; 1995 May; 146(5):1178-87. PubMed ID: 7747812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis.
    Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmström V
    Arthritis Res Ther; 2016 Apr; 18():80. PubMed ID: 27039301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis.
    Tang Q; Ramsköld D; Krystufkova O; Mann HF; Wick C; Dastmalchi M; Lakshmikanth T; Chen Y; Mikes J; Alexanderson H; Achour A; Brodin P; Vencovsky J; Lundberg IE; Malmström V
    Scand J Immunol; 2019 Jan; 89(1):e12732. PubMed ID: 30451307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.
    Wang DX; Lu X; Zu N; Lin B; Wang LY; Shu XM; Ma L; Wang GC
    Clin Rheumatol; 2012 Dec; 31(12):1691-7. PubMed ID: 22933126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
    Englund P; Wahlström J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
    Arthritis Rheum; 2007 Jan; 56(1):372-83. PubMed ID: 17195241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
    Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
    J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.
    Page G; Chevrel G; Miossec P
    Arthritis Rheum; 2004 Jan; 50(1):199-208. PubMed ID: 14730617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
    Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
    Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
    Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.